108-29-2|gamma-Valerolactone - Shanghai Canbi Pharma Ltd.

Current Location
Home Products
detail

gamma-Valerolactone | CAS:108-29-2

gamma-Valerolactone

Name：gamma-Valerolactone
CAS：108-29-2
Synonyms：4,5-Dihydro-5-methyl-2(3H)-furanone; 4-Hydroxypentanoic acid lactone
Molecular Formula：C₅H₈O₂
Molecular Weight：100.12
EINESC：203-569-5

Description

Properties

Melting point	-31 ºC
Water Solubility	MISCIBLE
Boiling point	207-208 ºC
Flash point	96 ºC
Density	1.05
Refractive index	1.432-1.434

Safety

Symbol(GHS)	Xi
Hazard Codes	R36
SDS/MSDS	S26;S39

SDS

Source	SDS/MSDS Samples
没有数据	没有数据

Synthetic Route

Name	CAS

Articles

Peer-Reviewed Papers

Treating PIK3CA and EGFR overexpressing breast cancers with lithium citrate.Toni M Brand et al.Cancer biology & therapy, 11(3), 368-370 (2011-01-14) Lithium citrate for Canavan disease.Christopher G Janson et al.Pediatric neurology, 33(4), 235-243 (2005-10-01) Quantification of physiological amino acids by gradient ion-exchange high-performance liquid chromatography.S E Møller Journal of chromatography, 613(2), 223-230 (1993-04-02) Lithium citrate reduces excessive intra-cerebral N-acetyl aspartate in Canavan disease.Assadi M, Janson C, Wang DJ, et al. European Journal of Pediatrics, 14, 354-359 (2010) Lithium citrate as treatment of Canavan disease.María Dolores Edo Solsona et al.Clinical neuropharmacology, 35(3), 150-151 (2012-05-18)

Remarks

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).

Name	CAS

Description

Properties

Safety

SDS

Related Products

Related News